| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Pres., R&D, And CMO | Chief Medical Officer, EVP R&D
1 company
Taub Rebecca is a Director at MADRIGAL PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $228.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 5, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Pres., R&D, And CMO | Sale+OE | 73,888 | $243.92 | $18,022,588.47 | -0.8% | +13.8% | +29.4% | |
| Jun 11, 2018 | MDGL Madrigal Pharmaceuticals, Inc. | Chief Medical Officer, EVP R&D | Sell | 73,526 | $287.46 | $21,135,783.96 | -10.1% | - | - |